NDC 55150-443
regadenoson
Regadenoson
regadenoson is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Eugia Us Llc. The primary component is Regadenoson.
| Product ID | 55150-443_b553eb2d-0c3f-444e-ad4c-282328683110 |
| NDC | 55150-443 |
| Product Type | Human Prescription Drug |
| Proprietary Name | regadenoson |
| Generic Name | Regadenoson |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-10-26 |
| Marketing Category | ANDA / |
| Application Number | ANDA216437 |
| Labeler Name | Eugia US LLC |
| Substance Name | REGADENOSON |
| Active Ingredient Strength | 0 mg/mL |
| Pharm Classes | Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |